Upcoming verified earnings release
BioCryst Pharmaceuticals Q4 2026 Earnings Preview
Direct answer
BioCryst Pharmaceuticals is scheduled to report Q4 2026 earnings on February 24, 2027.
After the US market closes. The available EPS estimate is 0.1131.
This page will keep the same address and add the reported result when the verified source provides it.
Verified earnings source
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- February 24, 2027
- Reported timing
- After the US market closes
- EPS estimate
- 0.1131
- Reported EPS
- Not provided
Explore related company data
Read the frequently asked questions.
When is BioCryst Pharmaceuticals scheduled to report Q4 2026 earnings?
BioCryst Pharmaceuticals is scheduled to report on February 24, 2027. The reported timing is after the us market closes.
What is the available EPS estimate for BioCryst Pharmaceuticals?
The verified record provides an EPS estimate of 0.1131.
Has BioCryst Pharmaceuticals reported the Q4 2026 result?
A reported result has not yet been verified. This same page will show the result after verification.
Which source supports this BioCryst Pharmaceuticals earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.